News
Clene (NASDAQ: CLNN) , a late clinical-stage biopharma company developing treatments for neurodegenerative diseases, reported Q2 2025 results and sai ...
By decoding neural signals linked to a person’s inner monologue, researchers enabled communication for individuals with ...
The Company plans to hold an end-of-Phase 2 Type B meeting with the FDA in the third quarter of 2025. This meeting will review results from the Phase 2 VISIONARY-MS trial and discuss the planned Phase ...
11h
TipRanks on MSNAthira Pharma presents results from Phase 1 trial of ATH-1105 at ALS Nexus
Athira Pharma (ATHA) presented results from its Phase 1 clinical trial of ATH-1105 in healthy volunteers at the ALS Nexus 2025 conference in ...
When approached for a quote about Jeffrey D Rothstein, Professor of Neurology and Neuroscience and Director of the Brain Science Institute at Johns Hopkins School of Medicine (Baltimore MD, USA), his ...
Therapeutic advances have altered the neurodegenerative trajectory and improved clinical outcomes for individuals with spinal muscular atrophy. Current therapies increase concentrations of survival ...
Sharon Stone emotionally detailed her years-long friendship with Eric Dane, including how she supported him in landing his ...
Stone will be joining Dane — whom she has been friends with "for a long time" — on the long-awaited third season of the HBO ...
Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie's Quest, today announced plans to ...
The dad and motorcycle racer thought his lack of coordination was from being tired. It was an early ALS symptom. Now, he's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results